Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Vaxcellbio is a bio-pharmaceutical company developing anti-cancer immunotherapies. Its primary business areas involve the development of Natural Killer (NK) cell therapies and Dendritic Cell (DC) therapies, with the goal of treating intractable cancers such as liver cancer and multiple myeloma. The company is currently conducting clinical research utilizing its Vax-NK and Vax-DC platforms.
박셀바이오는 항암면역치료제를 개발하는 바이오 기업입니다. 주요 사업 영역은 자연살해(NK)세포 치료제와 수지상세포(DC) 치료제 개발이며, 간암 및 다발골수종 등 난치성 암 치료를 목표로 하고 있습니다. 특히 Vax-NK와 Vax-DC 플랫폼을 활용하여 임상 연구를 진행 중입니다.
